Determination of the subcellular distribution of mercaptoundecahydro-closo-dodecaborate (BSH) in human glioblastoma multiforme by electron microscopy

Journal of Neuro-Oncology

Volumn 57, Issue 2, 2002, Pages 97-104

  Neumann, M ^a   Kunz, U ^b   Lehmann, H ^b   Gabel, D ^a  

^a UNIVERSITY OF BREMEN   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

BSH; EELS; ESI; Glioblastoma multiforme; Immunohistochemistry; Transmission electron microscopy

Indexed keywords

ANTIBODY; BOROCAPTATE; BORON 10; BORANE DERIVATIVE; THIOL DERIVATIVE;

ADULT; AGED; ARTICLE; CELL MEMBRANE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CHROMATIN; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTRON ENERGY LOSS SPECTROSCOPY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MALE; NEUTRON CAPTURE THERAPY; SENSITIVITY AND SPECIFICITY; SPECTROSCOPY; TISSUE SECTION; TRANSMISSION ELECTRON MICROSCOPY; BRAIN TUMOR; CELL FRACTIONATION; ELECTRON MICROSCOPY; METABOLISM; TISSUE DISTRIBUTION; ULTRASTRUCTURE;

BOROHYDRIDES; BORON NEUTRON CAPTURE THERAPY; BRAIN NEOPLASMS; GLIOBLASTOMA; HUMAN; MICROSCOPY, ELECTRON; SUBCELLULAR FRACTIONS; SULFHYDRYL COMPOUNDS; TISSUE DISTRIBUTION; HUMANS;

EID: 0035986176     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015737010621     Document Type: Article

References (26)

1. Detection of nuclear disintegration in a photographic emulsion
2. Range and stopping-power tables for heavy ions
3. New horizons for therapy based on the boron neutron capture reaction
4. Analytical calculation of boron-10 dosage in cell nucleus for neutron capture therapy
5. 7Li reaction in cells and tissue and its implication for boron neutron capture therapy
6. Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy
7. Boron-10-mercaptoundecahydrodo-decaborate distribution in human brain tumors as studied by neutron-induced alpha-autoradiography
8. 11SH
9. Performance of sulfhydryl boron hydride in patients with grade III and IV astrocytoma: A basis for boron neutron capture therapy
10. 11SH on cellular and subcellular level in tumor tissue of glioma patients in boron neutron capture therapy
11. 11SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT)
12. 11SH to tumor tissue of glioma patients in boron neutron capture therapy
13. Technik und biologische Anwendung der elektronenspektroskopischen Abbildung (ESI) und der Elektronen Energie-Verlust Spektroskopie (EELS)
14. Preparation of plant material for elemental analysis using ESI and EELS techniques
15. Lysine-rich histone (H1) is a lysyl substrate of tissue transglutaminase: Possible involvement of transglutaminase in the formation of nuclear aggregates in (CAG)(n)/Q(n) expansion diseases
16. Structural organization of the human gene (LMNB1) encoding nuclear lamin B1
17. In vitro posttranslational modification of lamin B cloned from a human T-cell line
18. Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins
19. cDNA sequencing of nuclear lamins A and C reveals primary and secondary structural homology to intermediate filament proteins
20. 11SH (BSH) with liposomes; Relevance to the cellular BSH uptake
21. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: Clinical relevance
22. Human brain tumors: Assessment with in vivo proton MR spectroscopy
23. Phagocytic capacity of normal and malignant rat glial cells in culture
24. 11SH